Class 3 Drug Alert (Action within 5 days): Glibenclamide 5 mg Tablets in Teva UK Limited and Generics (UK) Limited Livery - EL (10)A/17

---

Dear Healthcare Professional,

Product in Teva UK Limited Livery

Batch Number	Expiry Date	Pack Size	First Distributed
000537	September 2012	1x28	18 Nov 2009
001315	September 2012	1x28	11 Mar 2010

Product in Generics (UK) Limited Livery

Batch Number	Expiry Date	Pack Size	First Distributed
000681	September 2012	1x28	23 Nov 2009

Further to the Drug Alert issued by the MHRA on 15 March 2010 (EL (10)A/06 Rev 1) concerning the recall of some batches of this product due to issues with tablet dissolution during routine stability testing, Teva UK Limited has informed us that it has now received new stock. The three batches which remained on the market at the time in order to avoid market shortages are now being recalled by the company, see details in the tables above.

Remaining stocks of these batches should be returned to the original wholesaler for credit. For further stock enquiries please contact Teva UK Customer Liaison Team on 0800 590502.

For medical information enquiries please contact Teva UK Limited by phone on 0207 5407117 or by email at medinfo@tevauk.com. 

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Primary Care Trusts are asked to forward this to relevant clinics and to General Practitioners and community pharmacists for information.

Yours faithfully

Alison Bunce
Pharmaceutical Assessor, DMRC

 

MHRA Distribution (further recipients by cascade):

Regional contacts for NHS trusts and provider units
Chief pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special hospitals
Healthcare Commission for distribution to Independent Health Care Establishments
Primary care trusts (England)